Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$9,833 Mln
P/E Ratio
26.95
P/B Ratio
3.98
Industry P/E
--
Debt to Equity
22.51
ROE
0.16 %
ROCE
16.23 %
Div. Yield
1.19 %
Book Value
0.7
EPS
5.51
CFO
$4,106.53 Mln
EBITDA
$5,527.58 Mln
Net Profit
$2,235.49 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
AptarGroup (ATR)
| -5.12 | 0.72 | -5.84 | 6.46 | 8.52 | 7.44 | 8.94 |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
AptarGroup (ATR)
| 26.83 | 12.40 | -10.21 | -9.54 | 19.87 | 24.47 | 10.49 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 68.75 | 7,961.25 | 15.21 | 19.29 | |
| 89.31 | 10,446.05 | 25.16 | 16.42 | |
| 18.01 | 3,269.01 | -- | -10.86 | |
| 27.64 | 4,081.63 | 15.02 | 45.09 |
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company... operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois. Read more
President, CEO & Executive Director
Mr. Stephan B. Tanda
President, CEO & Executive Director
Mr. Stephan B. Tanda
Headquarters
Crystal Lake, IL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of AptarGroup Inc (ATR) stood at $ 4,432 Mln as on 31-Dec-24
The share price of AptarGroup Inc (ATR) is $149.06 (NYSE) as of 25-Apr-2025 16:10 EDT. AptarGroup Inc (ATR) has given a return of 8.52% in the last 3 years.
AptarGroup Inc (ATR) has a market capitalisation of $ 9,833 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of AptarGroup Inc (ATR) is 26.95 times as on 25-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the AptarGroup Inc (ATR) and enter the required number of quantities and click on buy to purchase the shares of AptarGroup Inc (ATR).
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
The CEO & director of Mr. Stephan B. Tanda. is AptarGroup Inc (ATR), and CFO & Sr. VP is Mr. Stephan B. Tanda.
There is no promoter pledging in AptarGroup Inc (ATR).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,018
|
|
|
798
|
|
|
394
|
|
|
327
|
| AptarGroup Inc. (ATR) | Ratios |
|---|---|
|
Return on equity(%)
|
31.81
|
|
Operating margin(%)
|
14.34
|
|
Net Margin(%)
|
10.45
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of AptarGroup Inc (ATR) was $0 Mln.
$-2.40
(
